BAM
RCEL icon

Belpointe Asset Management’s Avita Medical RCEL Stock Holding History

Belpointe Asset Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-20
Closed -$279 – 2711
2023
Q1 		$279 Hold
20
– – ﹤0.01% 3646
2022
Q4 		$132 Buy
+20
New +$120 ﹤0.01% 3660

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Belpointe Asset Management's RCEL Position: Q2 2023 in Review

Belpointe Asset Management sold out of Avita Medical (RCEL) in Q2 2023, closing a stake of 20 shares — an estimated $279 sold.

Belpointe Asset Management first reported a position in RCEL in Q4 2022 and held it in 2 quarters. The position peaked at $279 in Q1 2023. 80 funds tracked by Wall St. Rank hold RCEL as of Q2 2023.

  • Belpointe Asset Management reported no remaining Avita Medical position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 20 Avita Medical shares in Q2 2023, an estimated $279.
  • Belpointe Asset Management first reported a position in Avita Medical in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's Avita Medical position peaked at $279 in Q1 2023.
  • 80 funds tracked by Wall St. Rank held Avita Medical as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.